These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 16862429)

  • 1. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 3. Therapeutic efficacy and safety studies in ovarian cancer xenograft model.
    Devalapally H; Shenoy D; Little S; Langer R; Amiji M
    Cancer Chemother Pharmacol; 2007 Mar; 59(4):477-84. PubMed ID: 16862429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly(ethylene oxide)-modified poly(epsilon-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer.
    Shenoy DB; Amiji MM
    Int J Pharm; 2005 Apr; 293(1-2):261-70. PubMed ID: 15778064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of drug resistance in ovarian adenocarcinoma by enhancing intracellular ceramide using tamoxifen-loaded biodegradable polymeric nanoparticles.
    Devalapally H; Duan Z; Seiden MV; Amiji MM
    Clin Cancer Res; 2008 May; 14(10):3193-203. PubMed ID: 18483388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 2. In vivo distribution and tumor localization studies.
    Shenoy D; Little S; Langer R; Amiji M
    Pharm Res; 2005 Dec; 22(12):2107-14. PubMed ID: 16254763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluations of combination MDR-1 gene silencing and paclitaxel administration in biodegradable polymeric nanoparticle formulations to overcome multidrug resistance in cancer cells.
    Yadav S; van Vlerken LE; Little SR; Amiji MM
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):711-22. PubMed ID: 18618115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs. 1. In vitro evaluations.
    Shenoy D; Little S; Langer R; Amiji M
    Mol Pharm; 2005; 2(5):357-66. PubMed ID: 16196488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
    Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
    J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of polymeric pH-sensitive STEALTH® nanoparticles for tumor delivery of a lipophilic prodrug of paclitaxel.
    Lundberg BB
    Int J Pharm; 2011 Apr; 408(1-2):208-12. PubMed ID: 21296135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel self-associating poly(ethylene oxide)-b-poly(epsilon-caprolactone) based drug conjugates and nano-containers for paclitaxel delivery.
    Shahin M; Lavasanifar A
    Int J Pharm; 2010 Apr; 389(1-2):213-22. PubMed ID: 20080163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of intracellular ceramide using polymeric nanoparticles to overcome multidrug resistance in cancer.
    van Vlerken LE; Duan Z; Seiden MV; Amiji MM
    Cancer Res; 2007 May; 67(10):4843-50. PubMed ID: 17510414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro.
    Gou M; Zheng L; Peng X; Men K; Zheng X; Zeng S; Guo G; Luo F; Zhao X; Chen L; Wei Y; Qian Z
    Int J Pharm; 2009 Jun; 375(1-2):170-6. PubMed ID: 19427143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective antitumor activity of paclitaxel-loaded poly (epsilon-caprolactone)/pluronic F68 nanoparticles after intratumoral delivery into the murine breast cancer model.
    Ma G; Yang J; Zhang L; Song C
    Anticancer Drugs; 2010 Mar; 21(3):261-9. PubMed ID: 20016371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conjugation of arginine-glycine-aspartic acid peptides to poly(ethylene oxide)-b-poly(epsilon-caprolactone) micelles for enhanced intracellular drug delivery to metastatic tumor cells.
    Xiong XB; Mahmud A; Uludağ H; Lavasanifar A
    Biomacromolecules; 2007 Mar; 8(3):874-84. PubMed ID: 17315946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(epsilon-caprolactone)/poly(ethylene glycol)/poly(epsilon-caprolactone) nanoparticles: preparation, characterization, and application in doxorubicin delivery.
    Gou M; Zheng X; Men K; Zhang J; Zheng L; Wang X; Luo F; Zhao Y; Zhao X; Wei Y; Qian Z
    J Phys Chem B; 2009 Oct; 113(39):12928-33. PubMed ID: 19736995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(ethylene glycol)/poly(epsilon-caprolactone) diblock copolymeric nanoparticles for non-viral gene delivery: the role of charge group and molecular weight in particle formation, cytotoxicity and transfection.
    Jang JS; Kim SY; Lee SB; Kim KO; Han JS; Lee YM
    J Control Release; 2006 Jun; 113(2):173-82. PubMed ID: 16750279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model.
    Vassileva V; Grant J; De Souza R; Allen C; Piquette-Miller M
    Cancer Chemother Pharmacol; 2007 Nov; 60(6):907-14. PubMed ID: 17375303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive biodegradable system for paclitaxel delivery.
    Potineni A; Lynn DM; Langer R; Amiji MM
    J Control Release; 2003 Jan; 86(2-3):223-34. PubMed ID: 12526819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monolayer-protected gold nanoparticles by the self-assembly of micellar poly(ethylene oxide)-b-poly(epsilon-caprolactone) block copolymer.
    Azzam T; Eisenberg A
    Langmuir; 2007 Feb; 23(4):2126-32. PubMed ID: 17279704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel paclitaxel-loaded poly(epsilon-caprolactone)/Poloxamer 188 blend nanoparticle overcoming multidrug resistance for cancer treatment.
    Zhang Y; Tang L; Sun L; Bao J; Song C; Huang L; Liu K; Tian Y; Tian G; Li Z; Sun H; Mei L
    Acta Biomater; 2010 Jun; 6(6):2045-52. PubMed ID: 19969111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel and ceramide co-administration in biodegradable polymeric nanoparticulate delivery system to overcome drug resistance in ovarian cancer.
    Devalapally H; Duan Z; Seiden MV; Amiji MM
    Int J Cancer; 2007 Oct; 121(8):1830-8. PubMed ID: 17557285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.